Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    -1.00 (-0.39%)
Bid:
253.00
Ask:
255.00
Spread: 2.00 (0.791%)
Market Cap: £339.42m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Form 8.5 (EPT/RI) - Amendment

4 Aug 2021 07:46

RNS Number : 5327H
GoldmanSachs International
04 August 2021
 

- due to the amendment of Equity and Derivative transactions, the disclosure made on 30 July for dealings on 29 July has been updated. Sections 2(a) and 2(b) have been updated.

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

(GS) GOLDMAN SACHS INTERNATIONAL

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

RESTORE PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

MARLOWE PLC

(d) Date dealing undertaken:

29 July 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES - disclosed previously for MARLOWE PLC

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

5p ordinary

Purchases

4,556

4.7014 GBP

4.7014 GBP

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

5p ordinary

CFD

Reducing a long position

4,556

4.7005 GBP

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising / exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

04 August 2021

Contact name:

Paul Grainger and Kashif Rafiq

Telephone number:

+44(20) 7552 9835 / +44(20) 7051 0547

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUPUCCRUPGUQC
Date   Source Headline
4th Mar 20258:04 amRNSHolding(s) in Company
4th Feb 20259:23 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSNotice of full year results
21st Nov 20247:00 amRNSTrading Update
7th Nov 20247:00 amRNSNotice of Trading Update
31st Oct 20241:07 pmRNSHolding(s) in Company
24th Oct 20247:00 amRNSAnalyst and Investor Site Visit
22nd Oct 20242:26 pmRNSDirector/PDMR Shareholding
17th Oct 20247:00 amRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSBoard Change
2nd Sep 20247:00 amRNSDirector/PDMR Shareholding
23rd Aug 20249:21 amRNSDirector/PDMR Shareholding
16th Aug 202410:27 amRNSHolding(s) in Company
31st Jul 20247:00 amRNSHalf year results 2024
7th Jun 20247:49 amRNSHolding(s) in Company
3rd Jun 20241:17 pmRNSHolding(s) in Company
20th May 20242:03 pmRNSGrant of SAYE Options and PDMR Dealings
16th May 20244:29 pmRNSResult of Annual General Meeting
16th May 20247:00 amRNSTrading Update
12th Apr 20243:48 pmRNSHolding(s) in Company
5th Apr 20243:39 pmRNSDirector/PDMR Shareholding
25th Mar 20248:59 amRNSHolding(s) in Company
14th Mar 20247:00 amRNSFull year 2023 results
18th Jan 20247:00 amRNSTrading Update and Notice of Full Year Results
20th Dec 20237:00 amRNSHolding(s) in Company
18th Dec 202311:38 amRNSDirector/PDMR Shareholding
20th Nov 20234:07 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSTrading Update, Contract Award and CME
30th Oct 20237:00 amRNSBoard Changes
24th Oct 20233:33 pmRNSHolding(s) in Company
11th Oct 202312:07 pmRNSDirector/PDMR Shareholding
6th Oct 20233:52 pmRNSDirector/PDMR Shareholding
25th Sep 202310:55 amRNSDirector/PDMR Shareholding
22nd Sep 20234:43 pmRNSNotification of Major Holdings
12th Sep 20237:00 amRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSBoard Changes
16th Aug 20237:00 amRNSInterim CFO Appointment
16th Aug 20237:00 amRNSHalf Year Results 2023
1st Aug 20233:23 pmRNSNotification of Major Holdings
19th Jul 20232:35 pmRNSNotification of Major Holdings
4th Jul 20237:01 amRNSBoard Changes
4th Jul 20237:00 amRNSTrading Update
22nd Jun 20236:08 pmRNSDirector/PDMR, Grant of LTIP
14th Jun 20237:00 amRNSBoard Change
24th May 20234:37 pmRNSNOTIFICATION OF MAJOR HOLDINGS
18th May 20233:42 pmRNSNotification of Major Holdings
16th May 20234:18 pmRNSResult of Annual General Meeting
15th May 20237:00 amRNSTrading Update
11th Apr 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.